Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMLPNT0)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Etamsylate; ETHAMSYLATE; 2624-44-4; Cyclonamine; Altodor; Aglumin; Ciclonamina; Dicynone; Dicynene; Eselin; Ciclonamina [Italian]; Etamsylatum [INN-Latin]; Etamsilato [INN-Spanish]; UNII-24YL531VOH; Ethamsylate [USAN]; EINECS 220-090-7; MD 141; Benzenesulfonic acid, 2,5-dihydroxy-, compd. with N-ethylethanamine (1:1); 24YL531VOH; E 141; Diethylammonium 2,5-dihydroxybenzenesulfonate; Diethylammonium cyclohexadien-4-ol-1-one-4-sulfonate; Ethamsylate (USAN); Diidroxi-1,4-benzenesulfonato-3-di-etilammonium [Italian]; NCGC00017041-01
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||
|
|||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||
